Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient resources to ensure safe access to Wegovy. Novo Nordisk has announced ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

Starting today, the mass production or sale of non-approved "semaglutide" drugs is considered illegal under US compounding laws. Novo Nordisk is responding with a special offer for Wegovy ...

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...

The shortage allowed compounded pharmacies to produce the copycats at cheaper prices, made from variable forms of the key ingredients — semaglutide for Novo Nordisk's drug and tirzepatide for ...

PLAINSBORO, N.J., May 22, 2025 /PRNewswire/ -- Today, as the US Food and Drug Administration (FDA) grace period for mass compounding of "semaglutide" expires, Novo Nordisk announced a series of ...

One of the biggest risks Novo Nordisk faced was that companies like Hims & Hers could exploit a legal loophole to sell compounded semaglutide. A few weeks ago, however, a piece of news changed the ...

With a U.S. Food and Drug Administration ban on copycat semaglutide drugs now in effect, Novo Nordisk is launching a series of initiatives to improve access to authentic versions of its ...

rather than preparing and selling a generic semaglutide concoction of its own. Assuming this is indeed what's happening, Noom's approach might boost Novo Nordisk sales of Wegovy as Noom becomes a ...